Abstract
The performance of coronary artery bypass grafting (CABG) has improved with the development of percutaneous coronary intervention (PCI), while being compared with that of PCI. Recent randomized trials have reported the superiority of CABG over PCI in patients with diabetes and multi-vessel disease. CABG tends to involve minimally-invasive surgery, such as off-pump CABG, minimally-invasive direct coronary artery bypass, hybrid CABG and robotic-assisted CABG. The treatment of ischemic heart disease requires careful selection of the treatment method, in close cooperation with cardiologists and cardiac surgeons, and in consideration of the patient background and the coronary artery lesion.